A Phase Ib Study to Evaluate the Safety and Efficacy of Nivolumab in Combination with RCHOP in High-Risk DLBCL
Blood(2023)
Abstract
Introduction
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined